Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development

PLoS Pathogens

Volumn 13, Issue 7, 2017, Pages

  Kumar, Ritesh ^a   Herold, Jennifer L ^a   Schady, Deborah ^b   Davis, Jennifer ^c   Kopetz, Scott ^c   Martinez Moczygemba, Margarita ^a   Murray, Barbara E ^d,e   Han, Fang ^f   Li, Yu ^f   Callaway, Evelyn ^g   Chapkin, Robert S ^g   Dashwood, Wan Mohaiza ^a   Dashwood, Roderick H ^a   Berry, Tia ^a   Mackenzie, Chris ^e   Xu, Yi ^a,e,h  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f HARBIN INSTITUTE OF TECHNOLOGY   (China)

^g TEXAS A AND M UNIVERSITY   (United States)

^h TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLINE; CYTOKINE; MYC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CANCER CELL; COLON CARCINOGENESIS; COLORECTAL TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS GALLOLYTICUS SUBSP. GALLOLYTICUS; STREPTOCOCCUS INFECTION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; WESTERN BLOTTING; ANIMAL; DISEASE EXACERBATION; GENETICS; METABOLISM; MICROBIOLOGY; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; SIGNAL TRANSDUCTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS GALLOLYTICUS SUBSPECIES GALLOLYTICUS;

EID: 85026884966     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006440     Document Type: Article

References (82)

1. Cancer Facts & Figures 2013. American Cancer Society.
2. Siegel R, Desantis C, Jemal A, (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin64: 104–117. doi: 10.3322/caac.21220 24639052
3. Boleij A, Tjalsma H, (2012) Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc87: 701–730. doi: 10.1111/j.1469-185X.2012.00218.x 22296522
4. Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe14: 207–215. doi: 10.1016/j.chom.2013.07.007 23954159
5. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, et al. (2013) Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe14: 195–206. doi: 10.1016/j.chom.2013.07.012 23954158
6. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, et al. (2015) Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity42: 344–355. doi: 10.1016/j.immuni.2015.01.010 25680274
7. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science338: 120–123. doi: 10.1126/science.1224820 22903521
8. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med15: 1016–1022. doi: 10.1038/nm.2015 19701202
9. Wang X, Yang Y, Huycke MM, (2015) Commensal bacteria drive endogenous transformation and tumour stem cell marker expression through a bystander effect. Gut64: 459–468. doi: 10.1136/gutjnl-2014-307213 24906974
10. Dejea C, Wick E, Sears CL, (2013) Bacterial oncogenesis in the colon. Future Microbiol8: 445–460. doi: 10.2217/fmb.13.17 23534358
11. Garrett WS, (2015) Cancer and the microbiota. Science348: 80–86. doi: 10.1126/science.aaa4972 25838377
12. Sears CL, Garrett WS, (2014) Microbes, microbiota, and colon cancer. Cell Host Microbe15: 317–328. doi: 10.1016/j.chom.2014.02.007 24629338
13. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE, (2012) A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol10: 575–582. doi: 10.1038/nrmicro2819 22728587
14. Burnett-Hartman AN, Newcomb PA, Potter JD, (2008) Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev17: 2970–2979. doi: 10.1158/1055-9965.EPI-08-0571 18990738
15. Antonic V, Stojadinovic A, Kester KE, Weina PJ, Brucher BL, et al. (2013) Significance of infectious agents in colorectal cancer development. J Cancer4: 227–240. doi: 10.7150/jca.5835 23459622
16. Schlegel L, Grimont F, Ageron E, Grimont PA, Bouvet A, (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex and related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonicus subsp. nov. and S. gallolyticus subsp. pasteurianus subsp. nov. Int J Syst Evol Microbiol53: 631–645. doi: 10.1099/ijs.0.02361-0 12807180
17. Schlegel L, Grimont F, Grimont PA, Bouvet A, (2003) Identification of major Streptococcal species by rrn-amplified ribosomal DNA restriction analysis. J Clin Microbiol41: 657–666. doi: 10.1128/JCM.41.2.657-666.2003 12574263
18. Abdulamir AS, Hafidh RR, Bakar FA, (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res30: 11. doi: 10.1186/1756-9966-30-11 21247505
19. Boleij A, Tjalsma H, (2013) The itinerary of Streptococcus gallolyticus infection in patients with colonic malignant disease. Lancet Infect Dis13: 719–724. doi: 10.1016/S1473-3099(13)70107-5 23831427
20. Boleij A, van Gelder MM, Swinkels DW, Tjalsma H, (2011) Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis53: 870–878. doi: 10.1093/cid/cir609 21960713
21. Gupta A, Madani R, Mukhtar H, (2010) Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis12: 164–171. doi: 10.1111/j.1463-1318.2009.01814.x 19226366
22. Waisberg J, Matheus Cde O, Pimenta J, (2002) Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review. Arq Gastroenterol39: 177–180. 12778310
23. Alazmi W, Bustamante M, O'Loughlin C, Gonzalez J, Raskin JB, (2006) The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis. Dig Dis Sci51: 732–736. doi: 10.1007/s10620-006-3199-7 16614996
24. Gold JS, Bayar S, Salem RR, (2004) Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy. Arch Surg139: 760–765. doi: 10.1001/archsurg.139.7.760 15249410
25. Corredoira J, Grau I, Garcia-Rodriguez JF, Alonso-Garcia P, Garcia-Pais MJ, et al. (2015) The clinical epidemiology and malignancies associated with Streptococcus bovis biotypes in 506 cases of bloodstream infections. J Infect71: 317–325. doi: 10.1016/j.jinf.2015.05.005 25982024
26. Boleij A, Schaeps RM, Tjalsma H, (2009) Association between Streptococcus bovis and colon cancer. J Clin Microbiol47: 516. doi: 10.1128/JCM.01755-08 19189926
27. Klein RS, Recco RA, Catalano MT, Edberg SC, Casey JI, et al. (1977) Association of Streptococcus bovis with carcinoma of the colon. N Engl J Med297: 800–802. doi: 10.1056/NEJM197710132971503 408687
28. Lazarovitch T, Shango M, Levine M, Brusovansky R, Akins R, et al. (2012) The relationship between the new taxonomy of Streptococcus bovis and its clonality to colon cancer, endocarditis, and biliary disease. Infection41: 329–337. doi: 10.1007/s15010-012-0314-x 22886774
29. Wang T, Cai G, Qiu Y, Fei N, Zhang M, et al. (2012) Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J6: 320–329. doi: 10.1038/ismej.2011.109 21850056
30. Boleij A, Roelofs R, Danne C, Bellais S, Dramsi S, et al. (2012) Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients. Cancer Prev Res (Phila)5: 260–265.
31. Beck M, Frodl R, Funke G, (2008) Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J Clin Microbiol46: 2966–2972. doi: 10.1128/JCM.00078-08 18614655
32. Corredoira-Sanchez J, Garcia-Garrote F, Rabunal R, Lopez-Roses L, Garcia-Pais MJ, et al. (2012) Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis55: 491–496. doi: 10.1093/cid/cis434 22563018
33. Corredoira J, Garcia-Pais MJ, Coira A, Rabunal R, Garcia-Garrote F, et al. (2015) Differences between endocarditis caused by Streptococcus bovis and Enterococcus spp. and their association with colorectal cancer. Eur J Clin Microbiol Infect Dis34: 1657–1665. doi: 10.1007/s10096-015-2402-1 26017665
34. Corredoira J, Grau I, Garcia-Rodriguez JF, Garcia-Pais MJ, Rabunal R, et al. (2017) Colorectal neoplasm in cases of Clostridium septicum and Streptococcus gallolyticus subsp. gallolyticus bacteraemia. Eur J Intern Med.
35. Paritsky M, Pastukh N, Brodsky D, Isakovich N, Peretz A, (2015) Association of Streptococcus bovis presence in colonic content with advanced colonic lesion. World J Gastroenterol21: 5663–5667. doi: 10.3748/wjg.v21.i18.5663 25987793
36. Abdulamir AS, Hafidh RR, Bakar FA, (2010) Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer9: 249. doi: 10.1186/1476-4598-9-249 20846456
37. Kubben FJ, Peeters-Haesevoets A, Engels LG, Baeten CG, Schutte B, et al. (1994) Proliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferation. Gut35: 530–535. 7909785
38. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell17: 9–26. doi: 10.1016/j.devcel.2009.06.016 19619488
39. Novellasdemunt L, Antas P, Li VS, (2015) Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms. Am J Physiol Cell Physiol309: C511–521. doi: 10.1152/ajpcell.00117.2015 26289750
40. Guinney J, Dienstmann R, Wang X, de Reynies A, Schlicker A, et al. (2015) The consensus molecular subtypes of colorectal cancer. Nat Med21: 1350–1356. doi: 10.1038/nm.3967 26457759
41. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science281: 1509–1512. 9727977
42. Gonsalves FC, Klein K, Carson BB, Katz S, Ekas LA, et al. (2011) An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway. Proc Natl Acad Sci U S A108: 5954–5963. doi: 10.1073/pnas.1017496108 21393571
43. Abdulamir AS, Hafidh RR, Abu Bakar F, (2011) The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res30: 11. doi: 10.1186/1756-9966-30-11 21247505
44. Boleij A, Muytjens CM, Bukhari SI, Cayet N, Glaser P, et al. (2011) Novel clues on the specific association of Streptococcus gallolyticus subsp gallolyticus with colorectal cancer. J Infect Dis203: 1101–1109. doi: 10.1093/infdis/jiq169 21451000
45. ACS (2013) Cancer Facts & Figures 2013. American Cancer Society.
46. Brabletz S, Schmalhofer O, Brabletz T, (2009) Gastrointestinal stem cells in development and cancer. J Pathol217: 307–317. doi: 10.1002/path.2475 19031475
47. Gregorieff A, Clevers H, (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev19: 877–890. doi: 10.1101/gad.1295405 15833914
48. Giles RH, van Es JH, Clevers H, (2003) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta1653: 1–24. 12781368
49. Fodde R, Brabletz T, (2007) Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol19: 150–158. doi: 10.1016/j.ceb.2007.02.007 17306971
50. White BD, Chien AJ, Dawson DW, (2012) Dysregulation of Wnt/beta-catenin signaling in gastrointestinal cancers. Gastroenterology142: 219–232. doi: 10.1053/j.gastro.2011.12.001 22155636
51. Wu S, Morin PJ, Maouyo D, Sears CL, (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology124: 392–400. doi: 10.1053/gast.2003.50047 12557145
52. Kirikoshi H, Sekihara H, Katoh M, (2001) Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int J Oncol19: 533–536. 11494032
53. Gnad T, Feoktistova M, Leverkus M, Lendeckel U, Naumann M, (2010) Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled. Mol Cancer9: 31. doi: 10.1186/1476-4598-9-31 20137080
54. Sokolova O, Bozko PM, Naumann M, (2008) Helicobacter pylori suppresses glycogen synthase kinase 3beta to promote beta-catenin activity. J Biol Chem283: 29367–29374. doi: 10.1074/jbc.M801818200 18772141
55. Nakayama M, Hisatsune J, Yamasaki E, Isomoto H, Kurazono H, et al. (2009) Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem284: 1612–1619. doi: 10.1074/jbc.M806981200 18996844
56. Tsang YH, Lamb A, Romero-Gallo J, Huang B, Ito K, et al. (2010) Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene29: 5643–5650. doi: 10.1038/onc.2010.304 20676134
57. Liu Z, Xu X, Chen L, Li W, Sun Y, et al. (2012) Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem113: 1080–1086. doi: 10.1002/jcb.23440 22266963
58. Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, et al. (2008) RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell14: 226–237. doi: 10.1016/j.ccr.2008.08.004 18772112
59. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, et al. (2007) Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene26: 4617–4626. doi: 10.1038/sj.onc.1210251 17237808
60. Ress AL, Perakis S, Pichler M, (2015) microRNAs and Colorectal Cancer. Adv Exp Med Biol889: 89–103. doi: 10.1007/978-3-319-23730-5_6 26658998
61. Xuan Y, Yang H, Zhao L, Lau WB, Lau B, et al. (2015) MicroRNAs in colorectal cancer: small molecules with big functions. Cancer Lett360: 89–105. doi: 10.1016/j.canlet.2014.11.051 25524553
62. Saplacan RM, Mircea PA, Balacescu L, Balacescu O, (2015) MicroRNAs as non-invasive screening biomarkers of colorectal cancer. Clujul Med88: 453–456. doi: 10.15386/cjmed-568 26733742
63. Cekaite L, Eide PW, Lind GE, Skotheim RI, Lothe RA, (2015) MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer. Oncotarget.
64. Thomas J, Ohtsuka M, Pichler M, Ling H, (2015) MicroRNAs: Clinical Relevance in Colorectal Cancer. Int J Mol Sci16: 28063–28076. doi: 10.3390/ijms161226080 26602923
65. Libanio D, Dinis-Ribeiro M, Pimentel-Nunes P, (2015) Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol6: 111–132. doi: 10.5306/wjco.v6.i5.111 26468448
66. Roy BC, Subramaniam D, Ahmed I, Jala VR, Hester CM, et al. (2015) Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2. Oncogene34: 4519–4530. doi: 10.1038/onc.2014.386 25486432
67. Zang B, Huang G, Wang X, Zheng S, (2015) HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/beta-catenin signaling pathway. Int J Clin Exp Pathol8: 13687–13694. 26722596
68. Rusniok C, Couve E, Da Cunha V, El Gana R, Zidane N, et al. (2010) Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol192: 2266–2276. doi: 10.1128/JB.01659-09 20139183
69. Hinse D, Vollmer T, Ruckert C, Blom J, Kalinowski J, et al. (2011) Complete genome and comparative analysis of Streptococcus gallolyticus subsp. gallolyticus, an emerging pathogen of infective endocarditis. BMC Genomics12: 400. doi: 10.1186/1471-2164-12-400 21824414
70. Sillanpaa J, Nallapareddy SR, Qin X, Singh KV, Muzny DM, et al. (2009) A collagen-binding adhesin, Acb, and ten other putative MSCRAMM and pilus family proteins of Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis Group, biotype I). J Bacteriol191: 6643–6653. doi: 10.1128/JB.00909-09 19717590
71. Lin IH, Liu TT, Teng YT, Wu HL, Liu YM, et al. (2011) Sequencing and comparative genome analysis of two pathogenic Streptococcus gallolyticus subspecies: genome plasticity, adaptation and virulence. PLoS One6: e20519. doi: 10.1371/journal.pone.0020519 21633709
72. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF, (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A94: 10330–10334. 9294210
73. Wang Z, Vogelstein B, Kinzler KW, (2003) Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells. Cancer Res63: 5234–5235. 14500351
74. Martins M, Aymeric L, du Merle L, Danne C, Robbe-Masselot C, et al. (2015) Streptococcus gallolyticus Pil3 Pilus Is Required for Adhesion to Colonic Mucus and for Colonization of Mouse Distal Colon. J Infect Dis212: 1646–1655. doi: 10.1093/infdis/jiv307 26014801
75. Martins M, Porrini C, du Merle L, Danne C, Robbe-Masselot C, et al. (2016) The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen. Gut Microbes7: 526–532. doi: 10.1080/19490976.2016.1239677 27656949
76. Boleij A, Dutilh BE, Kortman GA, Roelofs R, Laarakkers CM, et al. (2012) Bacterial responses to a simulated colon tumor microenvironment. Mol Cell Proteomics11: 851–862. doi: 10.1074/mcp.M112.019315 22713208
77. Anderson RJ, Groundwater P. W., Todd A., Worsley A. J,. (2012) Trimethoprim, in Antibacterial Agents: Chemistry, Mode of Action, Mechanisms of Resistance and Clinical Applications. John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118325421 pp. 127–143.
78. Benham-Pyle BW, Pruitt BL, Nelson WJ, (2015) Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and beta-catenin activation to drive cell cycle entry. Science348: 1024–1027. doi: 10.1126/science.aaa4559 26023140
79. Russell BH, Vasan R, Keene DR, Xu Y, (2007) Bacillus anthracis internalization by human fibroblasts and epithelial cells. Cell Microbiol9: 1262–1274. doi: 10.1111/j.1462-5822.2006.00869.x 17474904
80. Sanceau J, Poupon MF, Delattre O, Sastre-Garau X, Wietzerbin J, (2002) Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene21: 7700–7709. doi: 10.1038/sj.onc.1205881 12400012
81. Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, et al. (2003) CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol162: 691–702. doi: 10.1016/S0002-9440(10)63863-1 12547727
82. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, et al. (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest98: 1010–1020. doi: 10.1172/JCI118861 8770874